Header Logo

Connection

Bette Caan to Colorectal Neoplasms

Back to Details
This is a "connection" page, showing publications Bette Caan has written about Colorectal Neoplasms.
Bette Caan
Connection Strength
6.419
Colorectal Neoplasms
  1. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control. 2022 Oct; 33(10):1219-1246.
    View in: PubMed
    Score: 0.526
  2. Non-alcoholic fatty liver disease and colorectal cancer survival. Cancer Causes Control. 2019 Feb; 30(2):165-168.
    View in: PubMed
    Score: 0.405
  3. Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative. Int J Cancer. 2017 12 01; 141(11):2281-2290.
    View in: PubMed
    Score: 0.373
  4. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017 07; 26(7):1008-1015.
    View in: PubMed
    Score: 0.365
  5. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
    View in: PubMed
    Score: 0.355
  6. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams. JAMA Oncol. 2016 Sep 01; 2(9):1137-45.
    View in: PubMed
    Score: 0.348
  7. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.
    View in: PubMed
    Score: 0.213
  8. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004 Mar 04; 350(10):991-1004.
    View in: PubMed
    Score: 0.146
  9. Body composition from single versus multi-slice abdominal computed tomography: Concordance and associations with colorectal cancer survival. J Cachexia Sarcopenia Muscle. 2022 12; 13(6):2974-2984.
    View in: PubMed
    Score: 0.132
  10. Weight stability masks changes in body composition in colorectal cancer: a retrospective cohort study. Am J Clin Nutr. 2021 06 01; 113(6):1482-1489.
    View in: PubMed
    Score: 0.121
  11. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative. JAMA Netw Open. 2020 09 01; 3(9):e2016747.
    View in: PubMed
    Score: 0.115
  12. The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer. J Natl Cancer Inst. 2020 04 01; 112(4):377-383.
    View in: PubMed
    Score: 0.111
  13. Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative. Cancer. 2020 04 15; 126(8):1766-1775.
    View in: PubMed
    Score: 0.110
  14. Body Composition and Cardiovascular Events in Patients With Colorectal Cancer: A Population-Based Retrospective Cohort Study. JAMA Oncol. 2019 Jul 01; 5(7):967-972.
    View in: PubMed
    Score: 0.106
  15. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer. 2020 02 01; 146(3):861-873.
    View in: PubMed
    Score: 0.105
  16. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 01; 51(1):76-87.
    View in: PubMed
    Score: 0.102
  17. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. 2018 06; 154(8):2152-2164.e19.
    View in: PubMed
    Score: 0.096
  18. The Optimal Body Mass Index Range for Patients With Colorectal Cancer-Reply. JAMA Oncol. 2017 05 01; 3(5):708.
    View in: PubMed
    Score: 0.091
  19. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.086
  20. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72.
    View in: PubMed
    Score: 0.085
  21. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer. 2016 Jan 19; 114(2):221-9.
    View in: PubMed
    Score: 0.083
  22. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis. 2016 Jan; 37(1):87-95.
    View in: PubMed
    Score: 0.082
  23. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun. 2015 Jul 07; 6:7138.
    View in: PubMed
    Score: 0.080
  24. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis. 2015 Sep; 36(9):999-1007.
    View in: PubMed
    Score: 0.080
  25. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1024-31.
    View in: PubMed
    Score: 0.079
  26. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17; 313(11):1133-42.
    View in: PubMed
    Score: 0.079
  27. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 2015 Jul 15; 137(2):428-38.
    View in: PubMed
    Score: 0.077
  28. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):198-205.
    View in: PubMed
    Score: 0.076
  29. Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1824-33.
    View in: PubMed
    Score: 0.075
  30. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet. 2014 Apr; 10(4):e1004228.
    View in: PubMed
    Score: 0.074
  31. Estimating the heritability of colorectal cancer. Hum Mol Genet. 2014 Jul 15; 23(14):3898-905.
    View in: PubMed
    Score: 0.073
  32. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2037-46.
    View in: PubMed
    Score: 0.071
  33. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 2014 May; 63(5):800-7.
    View in: PubMed
    Score: 0.070
  34. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer. 2013 May; 52(5):437-49.
    View in: PubMed
    Score: 0.068
  35. Genome-wide search for gene-gene interactions in colorectal cancer. PLoS One. 2012; 7(12):e52535.
    View in: PubMed
    Score: 0.067
  36. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
    View in: PubMed
    Score: 0.067
  37. A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev. 2012 Nov; 21(11):1974-85.
    View in: PubMed
    Score: 0.066
  38. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res. 2012 Apr 15; 72(8):2036-44.
    View in: PubMed
    Score: 0.064
  39. Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol. 2012 Apr; 36(2):e104-10.
    View in: PubMed
    Score: 0.063
  40. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Nutr Cancer. 2011 Nov; 63(8):1226-34.
    View in: PubMed
    Score: 0.062
  41. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012 Feb; 131(2):217-34.
    View in: PubMed
    Score: 0.061
  42. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3131-9.
    View in: PubMed
    Score: 0.058
  43. Red wine consumption not associated with reduced risk of colorectal cancer. Nutr Cancer. 2010; 62(6):849-55.
    View in: PubMed
    Score: 0.055
  44. Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative. Cancer Causes Control. 2008 Dec; 19(10):1291-8.
    View in: PubMed
    Score: 0.049
  45. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1344-53.
    View in: PubMed
    Score: 0.049
  46. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med. 2008 Mar 18; 148(6):419-26.
    View in: PubMed
    Score: 0.048
  47. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2752-5.
    View in: PubMed
    Score: 0.047
  48. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1745-52.
    View in: PubMed
    Score: 0.047
  49. The association between aspirin use and the incidence of colorectal cancer in women. Am J Epidemiol. 2006 Sep 15; 164(6):567-75.
    View in: PubMed
    Score: 0.043
  50. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr. 2006 Jul; 136(7):1896-903.
    View in: PubMed
    Score: 0.043
  51. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006 Jun 15; 118(12):3140-6.
    View in: PubMed
    Score: 0.043
  52. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev. 2006 Apr; 15(4):744-9.
    View in: PubMed
    Score: 0.042
  53. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006 Feb 16; 354(7):684-96.
    View in: PubMed
    Score: 0.042
  54. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):643-54.
    View in: PubMed
    Score: 0.042
  55. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr. 2005 Feb; 135(2):179-86.
    View in: PubMed
    Score: 0.039
  56. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004 Sep 20; 111(5):750-6.
    View in: PubMed
    Score: 0.038
  57. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1206-14.
    View in: PubMed
    Score: 0.037
  58. Meat intake and the recurrence of colorectal adenomas. Eur J Cancer Prev. 2004 Jun; 13(3):159-64.
    View in: PubMed
    Score: 0.037
  59. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control. 2003 Jun; 14(5):403-11.
    View in: PubMed
    Score: 0.035
  60. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst. 2001 Dec 05; 93(23):1799-805.
    View in: PubMed
    Score: 0.031
  61. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000 Apr 20; 342(16):1149-55.
    View in: PubMed
    Score: 0.028
  62. A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics. Am J Hum Genet. 2018 05 03; 102(5):904-919.
    View in: PubMed
    Score: 0.024
  63. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.
    View in: PubMed
    Score: 0.016
  64. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
    View in: PubMed
    Score: 0.009
  65. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer. 1998 Oct 05; 78(2):157-60.
    View in: PubMed
    Score: 0.006

© 2024 Kaiser Permanente